Researchers Developed New ArteryX Stroke Analysis Tool

A new software tool significantly reduces the time needed to analyze brain arteries in medical imaging.

Updated on Oct. 14, 2026 in Stroke

Isometric editorial illustration of a branching cerebral artery structure, rendered in matte geometric volumes to represent quantitative medical analysis. — University of Rochester Medicine researchers developed ArteryX, a new software tool designed to automate quantitative vessel analysis from brain MRI images. AI Illustration. Upload story photo >

Live Poll

Should medical research prioritize developing automated software tools to improve diagnostic speed and accuracy?

University of Rochester Medicine researchers have developed ArteryX, a new software tool that automates the measurement of brain arteries using MRI images. The technology significantly reduces the time required for quantitative vessel analysis compared to previous methods.

Why it matters

Manual analysis of brain vessel MRI images is notoriously time-consuming and often introduces variability between clinicians. Automating this process creates a more reliable and consistent approach for critical brain-vessel research.

ArteryX requires 10 to 15 minutes of processing and interaction time to analyze brain arteries. This represents a substantial efficiency gain over the iCafe software tool, which currently requires approximately 1.5 hours to complete the same task.

The players

University of Rochester Medicine

This academic medical center served as the primary site where researchers developed the new ArteryX software.

National Institutes of Health

This federal agency provided the grant funding necessary for the development of the ArteryX research tool.

The details

The software functions by analyzing three-dimensional time-of-flight magnetic resonance angiography images to generate standardized metrics. These include vessel length, radius, volume, surface area, branching, and tortuosity, allowing the system to identify vascular differences in patients with and without cerebral small vessel disease.

October 14, 2026: The research team published their findings regarding the ArteryX tool.

The Big Picture

This development follows the research priorities established by the National Institutes of Health-funded grant for cerebral small vessel disease research. It marks a significant departure from manual imaging techniques by shifting toward fully automated, high-throughput diagnostic analysis.

While currently restricted to academic use, the tool could eventually lead to faster and more accurate stroke risk assessments in hospital settings. Patients may benefit from more precise diagnostic outcomes once the software is validated for wider clinical application.

The takeaway

The development of ArteryX highlights the ongoing trend of leveraging automation to reduce human error and variability in medical diagnostics. Researchers are now looking to integrate blood flow data with structural artery measurements to further enhance the utility of the platform.